Method for inhibiting the expression of Fas
US6096777A · kind A · utility
9Cited by
1References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 22, 1999 |
| Grant date | Aug 1, 2000 |
| Priority date | — |
| Expiry date | Feb 22, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a new method of treatment using compounds which are dual non-selective beta-adrenoceptor and alpha-1-adrenoceptor antagonists, in particularly the carbazolyl-(4)-oxypropanolainine compounds of Formula 1, as defined herein, for inhibiting the expression of Fas, a cell surface protein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.